Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 11
Submit an article Journal homepage
1,538
Views
10
CrossRef citations to date
0
Altmetric
Research Papers

Lasting immune memory against hepatitis B in 12–13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

Ulrich BehrePediatric Practice, Kehl, Baden-Württemberg, Germany
,
Olivier Van Der MeerenGSK Vaccines, Wavre, Belgium
,
Priya CrastaGSK Vaccines, Bangalore, India
,
Linda HanssensGSK Vaccines, Wavre, Belgium
&
Narcisa MesarosGSK Vaccines, Wavre, BelgiumCorrespondence[email protected]
(Dr.)
Pages 2916-2920 | Received 03 Mar 2016, Accepted 13 Jun 2016, Published online: 21 Sep 2016

References

  • Elizabeth W. Hwang RC. Global epidemiology of hepatitis B virus (HBV) infection. N Am J Med Sci 2011; 4:7–13.
  • Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386:1546–55.; PMID:26231459; http://dx.doi.org/10.1016/S0140-6736(15)61412-X
  • World Health Organization. Hepatitis B - Prevention and treatment. 2015. Available at http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index5.html. Accessed on September 2, 2015.
  • Steiner M, Ramakrishnan G, Gartner B, Van Der Meeren O, Jacquet JM, Schuster V. Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life. BMC Infect Dis 2010; 10:9; PMID:20078876; http://dx.doi.org/10.1186/1471-2334-10-9
  • Avdicova M, Crasta PD, Hardt K, Kovac M. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age. Vaccine 2015; 33:2727–33; PMID:24962750; http://dx.doi.org/10.1016/j.vaccine.2014.06.070
  • Behre U, Bleckmann G, Crasta PD, Leyssen M, Messier M, Jacquet JM, Hardt K. Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother 2012; 8:813–8; PMID:22508412; http://dx.doi.org/10.4161/hv.19898
  • Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand. Hum Vaccin Immunother 2013; 9:1679–84; PMID:23732904; http://dx.doi.org/10.4161/hv.24844
  • Zepp F, Schmitt HJ, Cleerbout J, Verstraeten T, Schuerman L, Jacquet JM. Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine). Exp Rev Vaccines 2009; 8:663–78; PMID:19485747; http://dx.doi.org/10.1586/erv.09.32
  • Dhillon S. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa). BioDrugs 2010; 24:299–302; PMID:20795752; http://dx.doi.org/10.2165/11206690-000000000-00000
  • Zinke M, Kappes R, Kindler K, Paulus-Koschik A, Goering U, Disselhoff J, Soemantri P, Grunert D, Laakmann KH, Gunasekaran R. Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine. Hum Vaccin 2009; 5:592–8; PMID:19535920; http://dx.doi.org/10.4161/hv.9051
  • Jorgensen P, Poethko-Muller C, Hellenbrand W, Jilg W, Thierfelder W, Meyer C, an der Heiden M, Schlaud M, Radun D. Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006. Epidemiol Infect 2010; 138:1621–9; PMID:20233496; http://dx.doi.org/10.1017/S0950268810000543
  • Van Der Meeren O, Bleckmann G, Crasta PD. Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix hexa) vaccine. Hum Vaccin Immunother 2014; 10:1682–7; PMID:24637296; http://dx.doi.org/10.4161/hv.28480
  • Heininger U, Sanger R, Jacquet JM, Schuerman L. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Vaccine 2007; 25:1055–63; PMID:17049692; http://dx.doi.org/10.1016/j.vaccine.2006.09.060
  • Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379–84; PMID:16226616; http://dx.doi.org/10.1016/S0140-6736(05)67568-X
  • Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28:730–6; PMID:19892043; http://dx.doi.org/10.1016/j.vaccine.2009.10.074
  • Keating GM, Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63:1021–51; PMID:12699402; http://dx.doi.org/10.2165/00003495-200363100-00006
  • McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200: 1390–6; PMID:19785526; http://dx.doi.org/10.1086/606119

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.